🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Sharing our article in Discover Oncology, which succinctly summarizes our current practice and challenges in diffuse large B-cell lymphoma management in Singapore. Take a peek! rdcu.be/dhgY0 #lymphoma #dlbcl Lymphoma Hub

Fresh out of the oven - the AITL-PI score! Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter study tandfonline.com/doi/full/10.10… #lymphoma

At #CTOS2023 catching up on #sarcoma and sharing our ongoing work on #angiosarcoma. It's back home soon to prepare for #ESMOAsia2023! Valerie Yang MBBChir PhD Herbert Loong, MBBS, FASCO Everett Moding, MD, PhD Tarek Assi

Are you ready for #ESMOAsia23? We have an exciting program line-up this year for #lymphoma!

Sharing our latest work on "Single‐Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T‐Cell Lymphoma" in Advanced Science #lymphoma #NKTCL #Asianlymphoma Lymphoma Hub onlinelibrary.wiley.com/doi/10.1002/ad…

Taking a sneak peak at the #ASH23 oral abstracts for T/NK cell lymphoma #lymphoma #nktcl #ptcl Lymphoma Hub Lymphoma Research Foundation The Leukemia & Lymphoma Society

👎 Systemic methotrexate did not reduce CNS progression in high-risk aggressive B-cell #Lymphoma. 👉 brnw.ch/21wEqUX #lymsm Katharine Lewis Chan Cheah

Join us 1 day before #ESMOAsia23 at the APAC Lymphoma Forum 2023! We have an exciting evening discussing 1L DLBCL care in Asia! #lymphoma #ALSG

Good morning!

Hightlight of the morning with these folks from the ESMO LGP Alumni!

Nothing makes me happier than being part of the #lymphoma family. Truly appreciative of our friends from afar #ALSG #ALLG #ESMOAsia23 who have graciously accepted our invitation to visit our new centre and for a wonderful discussion on how to do better for our patients.

Just out - our new "solitary fibrous tumor" cell-line model we named SFT-S1. Link to full text: rdcu.be/dtczI #starlightinitiative #rarecancers #rarecancersg #sarcoma

🔥Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing Cancer Treatment Reviews doi.org/10.1016/j.ctrv… 👉Understand all the advantages & disadvantages of hybrid capture vs amplicon-based enrichment and DNA vs RNA based NGS ESMO - Eur. Oncology EASL Education

A 70-year-old man undergoing cholangioscopy to evaluate dilatation of the common bile duct was found to have flatworms in his biliary tract (shown in a video). Read the full clinical case: nej.md/3NAhXE0

Summary of 10 new indications/approvals in Heme Malignancies (excluding CART) by FDA Oncology in 2023: 1. #Zanubrutinib 2. #Pirtobrutinib 3. #Polatuzumab 4. #Epcortimab 5. #Glofitamab 6. #Quizartinib 7. #Talquetamab 8. #Elranatamab 9. #Ivosidenib #HemeTwitter #MedTwitter

Sharing our latest paper in #Blood! Single-cell landscape of idiopathic Multicentric Castleman Disease in identical twins doi.org/10.1182/blood.… #rarecancersg #starlightinitiative #lymphoma #cancerdiscoveryhub

Wow way to go Wai Leong Tam !!

rdcu.be/dJGyU Sharing our latest article: Chang, E.W.Y., Tan, Y.H. & Chan, J.Y. Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma. J Hematol Oncol 17, 38 (2024). #lymphoma #ptcl

Join us for Singapore Lymphoma Scientific Symposium #SLSS2024 August 23rd to 25th! Check out the outstanding faculty and program this year. Abstract submission is still open! Registration is FREE. form.gov.sg/65a4dcf4d34ff9…